anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

183,541-183,600 of 319,975

filter-aware
07
The slide highlights a 4-year trend of plenary presentations and specific drug trial updates.AstraZeneca | Investor Day Presentation Deck | 43 slides · AstraZeneca
Conference presentation Investor relations Beat · Key Performance Indicators Overview1 hit
08
Includes a headshot of Susan Galbraith and a stylized illustration of a drug molecule/mechanism.AstraZeneca | Investor Day Presentation Deck | 43 slides · AstraZeneca
Conference presentation Investor relations 1 hit
09
The slide uses a biological process diagram to explain the drug's mechanism and a list to categorize clinical milestones.AstraZeneca | Investor Day Presentation Deck | 43 slides · AstraZeneca
Conference presentation Investor relations 1 hit
10
The slide uses a matrix-like layout to map treatment lines against cancer types, emphasizing the 'replace' strategy in existing markets and 'broaden/expand' strategy in new markets.AstraZeneca | Investor Day Presentation Deck | 43 slides · AstraZeneca
Conference presentation Investor relations Beat · Roadmap1 hit
11
The slide uses a donut chart to represent the distribution of HER2 expression levels in breast cancer patients.AstraZeneca | Investor Day Presentation Deck | 43 slides · AstraZeneca
Conference presentation Investor relations 1 hit
12
Waterfall plot shows N=50. Spider plot shows longitudinal response over weeks.AstraZeneca | Investor Day Presentation Deck | 43 slides · AstraZeneca
Conference presentation Investor relations 1 hit
13
Includes AstraZeneca branding and a medical illustration of an antibody-drug conjugate.AstraZeneca | Investor Day Presentation Deck | 43 slides · AstraZeneca
Conference presentation Investor relations 1 hit
14
The slide uses a standard clinical trial flow diagram (randomization process).AstraZeneca | Investor Day Presentation Deck | 43 slides · AstraZeneca
Conference presentation Investor relations 1 hit
15
Includes highlighted rows for HER2 status, Hormone receptor status, and metastatic sites.AstraZeneca | Investor Day Presentation Deck | 43 slides · AstraZeneca
Conference presentation Investor relations 1 hit
16
The table highlights median lines of therapy and specific categories of prior treatment exposure.AstraZeneca | Investor Day Presentation Deck | 43 slides · AstraZeneca
Conference presentation Investor relations 1 hit
17
Clinical trial data presentation showing mPFS and Hazard Ratios.AstraZeneca | Investor Day Presentation Deck | 43 slides · AstraZeneca
Conference presentation Investor relations 1 hit
18
Includes hazard ratios, confidence intervals, p-values, and median overall survival (mOS) for each cohort.AstraZeneca | Investor Day Presentation Deck | 43 slides · AstraZeneca
Conference presentation Investor relations 1 hit
19
The slide uses a forest plot to visualize hazard ratios with 95% confidence intervals for multiple clinical subgroups.AstraZeneca | Investor Day Presentation Deck | 43 slides · AstraZeneca
Conference presentation Investor relations 1 hit
20
Includes detailed footnotes defining abbreviations and study parameters.AstraZeneca | Investor Day Presentation Deck | 43 slides · AstraZeneca
Conference presentation Investor relations 1 hit
21
Includes clinical trial data for DESTINY-Breast04.AstraZeneca | Investor Day Presentation Deck | 43 slides · AstraZeneca
Conference presentation Investor relations Beat · Key Takeaways1 hit
22
AstraZeneca | Investor Day Presentation Deck | 43 slidesAstraZeneca | Investor Day Presentation Deck | 43 slides · AstraZeneca
Conference presentation Investor relations 1 hit
23
The slide uses a chronological sequence of Kaplan-Meier survival curves to show the evolution of the drug's efficacy across different patient lines.AstraZeneca | Investor Day Presentation Deck | 43 slides · AstraZeneca
Conference presentation Investor relations 1 hit
24
The chart is a stacked bar chart illustrating the composition of breast cancer subtypes.AstraZeneca | Investor Day Presentation Deck | 43 slides · AstraZeneca
Conference presentation Investor relations Beat · Problem1 hit
25
The slide uses a horizontal bar chart format to compare treatment durations across different lines of therapy (2L+, 3L+, 4L+).AstraZeneca | Investor Day Presentation Deck | 43 slides · AstraZeneca
Conference presentation Investor relations 1 hit
26
The chart uses a stacked bar approach to illustrate market penetration and clinical trial coverage (DESTINY-Breast04/06) across treatment lines.AstraZeneca | Investor Day Presentation Deck | 43 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
27
AstraZeneca | Investor Day Presentation Deck | 43 slidesAstraZeneca | Investor Day Presentation Deck | 43 slides · AstraZeneca
Conference presentation Investor relations 1 hit
28
The slide contrasts clinical efficacy data (waterfall plot) with a clinical trial design schematic.AstraZeneca | Investor Day Presentation Deck | 43 slides · AstraZeneca
Conference presentation Investor relations 1 hit
29
The slide uses a complex matrix layout to map patient segments (rows) against treatment lines (columns).AstraZeneca | Investor Day Presentation Deck | 43 slides · AstraZeneca
Conference presentation Investor relations 1 hit
30
The slide uses a matrix-like layout to show standard of care vs. clinical trial intervention points.AstraZeneca | Investor Day Presentation Deck | 43 slides · AstraZeneca
Conference presentation Investor relations 1 hit
31
The slide presents clinical trial data (Kaplan-Meier curve and summary table) and a trial design flowchart.AstraZeneca | Investor Day Presentation Deck | 43 slides · AstraZeneca
Conference presentation Investor relations 1 hit
32
Includes AACR 2022 conference branding.AstraZeneca | Investor Day Presentation Deck | 43 slides · AstraZeneca
Conference presentation Investor relations 1 hit
33
Includes a spider plot (left) and a waterfall plot (right) to demonstrate efficacy.AstraZeneca | Investor Day Presentation Deck | 43 slides · AstraZeneca
Conference presentation Investor relations 1 hit
34
Includes waterfall plot and spider plots for clinical trial data.AstraZeneca | Investor Day Presentation Deck | 43 slides · AstraZeneca
Conference presentation Investor relations 1 hit
35
The slide uses Kaplan-Meier survival curves to demonstrate clinical efficacy.AstraZeneca | Investor Day Presentation Deck | 43 slides · AstraZeneca
Conference presentation Investor relations 1 hit
36
AstraZeneca | Investor Day Presentation Deck | 43 slidesAstraZeneca | Investor Day Presentation Deck | 43 slides · AstraZeneca
Conference presentation Investor relations 1 hit
37
AstraZeneca | Investor Day Presentation Deck | 43 slidesAstraZeneca | Investor Day Presentation Deck | 43 slides · AstraZeneca
Conference presentation Investor relations 1 hit
38
AstraZeneca | Investor Day Presentation Deck | 43 slidesAstraZeneca | Investor Day Presentation Deck | 43 slides · AstraZeneca
Conference presentation Investor relations 1 hit
39
AstraZeneca | Investor Day Presentation Deck | 43 slidesAstraZeneca | Investor Day Presentation Deck | 43 slides · AstraZeneca
Conference presentation Investor relations 1 hit
40
The slide presents clinical trial data comparing T-DXd against TPC in two patient cohorts (HR+ and HR-).AstraZeneca | Investor Day Presentation Deck | 43 slides · AstraZeneca
Conference presentation Investor relations 1 hit
41
Waterfall plot showing individual patient responses; asterisks denote HR-negative disease.AstraZeneca | Investor Day Presentation Deck | 43 slides · AstraZeneca
Conference presentation Investor relations 1 hit
42
AstraZeneca | Investor Day Presentation Deck | 43 slidesAstraZeneca | Investor Day Presentation Deck | 43 slides · AstraZeneca
Conference presentation Investor relations 1 hit
43
AstraZeneca | Investor Day Presentation Deck | 43 slidesAstraZeneca | Investor Day Presentation Deck | 43 slides · AstraZeneca
Conference presentation Investor relations 1 hit
01
Slide 1
Azek | Investor Day Presentation Deck | 166 slidesAzek | Investor Day Presentation Deck | 166 slides · The AZEK Company
Conference presentation Investor relations Beat · Attention1 hit
02
Azek | Investor Day Presentation Deck | 166 slidesAzek | Investor Day Presentation Deck | 166 slides · The AZEK Company
Conference presentation Investor relations Beat · Attention1 hit
03
Azek | Investor Day Presentation Deck | 166 slidesAzek | Investor Day Presentation Deck | 166 slides · The AZEK Company
Conference presentation Investor relations Beat · Attention1 hit
04
Azek | Investor Day Presentation Deck | 166 slidesAzek | Investor Day Presentation Deck | 166 slides · The AZEK Company
Conference presentation Investor relations Beat · Attention1 hit
05
The slide uses a grid layout to present 11 individual executive profiles.Azek | Investor Day Presentation Deck | 166 slides · The AZEK Company
Conference presentation Investor relations 1 hit
06
The slide uses a grid layout to display headshots and biographical bullet points for each executive.Azek | Investor Day Presentation Deck | 166 slides · The AZEK Company
Conference presentation Investor relations 1 hit
07
Investor Day presentation slide.Azek | Investor Day Presentation Deck | 166 slides · The AZEK Company
Conference presentation Investor relations 1 hit
08
The visual element is a stylized circular flow diagram with the company logo in the center.Azek | Investor Day Presentation Deck | 166 slides · The AZEK Company
Conference presentation Investor relations 1 hit
09
Azek | Investor Day Presentation Deck | 166 slidesAzek | Investor Day Presentation Deck | 166 slides · The AZEK Company
Conference presentation Investor relations 1 hit
10
The chart uses a line-and-bubble visualization to represent market expansion over time.Azek | Investor Day Presentation Deck | 166 slides · The AZEK Company
Conference presentation Investor relations Beat · Need1 hit
11
The slide uses a split-layout to categorize two distinct business units under the 'Commercial Segment' umbrella.Azek | Investor Day Presentation Deck | 166 slides · The AZEK Company
Conference presentation Investor relations Beat · Need1 hit
12
Azek | Investor Day Presentation Deck | 166 slidesAzek | Investor Day Presentation Deck | 166 slides · The AZEK Company
Conference presentation Investor relations Beat · Need1 hit
13
The slide uses a 'before-after' or 'input-output' style logic to show how their business and network foundations lead to market-leading growth.Azek | Investor Day Presentation Deck | 166 slides · The AZEK Company
Conference presentation Investor relations Beat · Need1 hit
14
The slide uses a process-flow style diagram to link inputs (Markets, Strengths, Strategy) to outcomes (Tailwinds, Margins, Performance).Azek | Investor Day Presentation Deck | 166 slides · The AZEK Company
Conference presentation Investor relations Beat · Need1 hit
15
Azek | Investor Day Presentation Deck | 166 slidesAzek | Investor Day Presentation Deck | 166 slides · The AZEK Company
Conference presentation Investor relations Beat · Need1 hit
16
The slide uses a two-column layout to contrast market demand (left) with product conversion potential (right).Azek | Investor Day Presentation Deck | 166 slides · The AZEK Company
Conference presentation Investor relations 1 hit
17
Azek | Investor Day Presentation Deck | 166 slidesAzek | Investor Day Presentation Deck | 166 slides · The AZEK Company
Conference presentation Investor relations 1 hit
18
The slide uses a temple-style architectural metaphor to represent the company's strategic pillars.Azek | Investor Day Presentation Deck | 166 slides · The AZEK Company
Conference presentation Investor relations Beat · Satisfaction1 hit
19
Azek | Investor Day Presentation Deck | 166 slidesAzek | Investor Day Presentation Deck | 166 slides · The AZEK Company
Conference presentation Investor relations Beat · Satisfaction1 hit
20
Uses a stack/layering visual metaphor to represent growth components.Azek | Investor Day Presentation Deck | 166 slides · The AZEK Company
Conference presentation Investor relations Beat · Satisfaction1 hit
21
The slide uses imagery of outdoor living spaces to represent the company's product focus alongside financial metrics.Azek | Investor Day Presentation Deck | 166 slides · The AZEK Company
Conference presentation Investor relations Beat · Satisfaction1 hit
22
The slide uses a split-screen composition to demonstrate the transformation of waste materials into a premium product.Azek | Investor Day Presentation Deck | 166 slides · The AZEK Company
Conference presentation Investor relations Beat · Satisfaction1 hit
23
Azek | Investor Day Presentation Deck | 166 slidesAzek | Investor Day Presentation Deck | 166 slides · The AZEK Company
Conference presentation Investor relations Beat · Satisfaction1 hit